anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

212,881-212,940 of 319,975

filter-aware
54
The slide uses a three-column layout to define technical requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
55
The slide uses a traffic-light color coding system to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
56
The slide uses a linear process framework to explain the drug discovery pipeline.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
57
The slide uses a Pareto front to illustrate the trade-off between CNS score and Potency, highlighting the selection of 'unattractive' compounds.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
58
The slide shows two charts: a line chart for tumour volume over time and a dot plot for plasma Pro-GRP concentration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
59
The slide uses two distinct chart types (dot plot and line chart) to demonstrate the safety profile of a reversible inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
60
The chart shows a statistically significant difference (****) between the vehicle control and the treatment groups.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
61
The slide uses a two-column layout to contrast PK data with Toxicology/Safety data.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
62
The slide uses a split-layout to contrast current operational status with high-level program benefits.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
63
The slide uses a stylized molecular visualization as a background, typical of biotech pitch decks.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
64
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
65
Scientific/medical context slide explaining a therapeutic target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
66
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
67
The slide uses a scientific mechanism-of-action argument to establish a competitive moat.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
68
The slide uses a heatmap-style table to compare the company's asset against competitors, with a specific callout box around the UGT1A1 row.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
69
The slide uses a process-based framework to show how MD and AI are integrated into a drug discovery workflow.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
70
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
71
The chart displays tumour volume over time (D20-D48) with error bars representing standard deviation and statistical significance markers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
72
The chart shows tumor volume over time (D20-D30), with the combination therapy (teal line) showing a flat growth curve compared to monotherapies and vehicle controls.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
73
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
74
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
75
This is a standard corporate contact/disclaimer slide.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
01
Slide 1
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
02
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a dual-track timeline approach (Pipeline vs Platform/Corporate) for 1H 2023, followed by a list for 2H 2023.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
04
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Attention1 hit
05
The diagram represents a closed-loop iterative process for drug discovery.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a cyclical process flow to represent an adaptive clinical trial framework.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a visual list of protein structures to represent drug candidates.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
08
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Need1 hit
09
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The chart uses a horizontal bar format to represent development stages. One bar is orange (EXS4318), while the others are teal.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
11
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
The slide outlines a standard oncology clinical trial design (Phase 1/2) with a transition point at RP2D (Recommended Phase 2 Dose).Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
13
The slide uses a human anatomy diagram to map specific cancer types to their respective locations in the body.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
14
The waterfall plot shows sensitivity vs resistance; the right side shows pathway analysis and combination testing strategy.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
15
The slide uses a combination of a bar chart for single-agent sensitivity and a heatmap for combination synergy results.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
16
The Venn diagram illustrates the overlap of genes modulated by '617 in peripheral blood vs primary tumours, highlighting the potential for non-invasive biomarker monitoring.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
17
The slide highlights financial stability despite fluctuations in cash inflows from collaborations.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
18
The slide uses a dual-track timeline (Pipeline Progress vs Platform and Corporate Advancements) for 1H23, followed by a list for 2H23.Exscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
19
Exscientia | Results Presentation Deck | 19 slidesExscientia | Results Presentation Deck | 19 slides · Exscientia
Conference presentation Investor relations Beat · Action1 hit
01
Slide 1
Faraday Future | Results Presentation Deck | 36 slidesFaraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Attention1 hit
02
Faraday Future | Results Presentation Deck | 36 slidesFaraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Attention1 hit
03
Faraday Future | Results Presentation Deck | 36 slidesFaraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Attention1 hit
04
Faraday Future | Results Presentation Deck | 36 slidesFaraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Attention1 hit
05
The slide uses a high-contrast background image of the vehicle to emphasize the 'TechLuxury' brand identity.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Need1 hit
06
The slide uses a minimalist icon-based layout to present four pillars: All-AI, All-Hyper, All-Ability, and Co-Creation.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Need1 hit
07
The slide uses a layered architecture approach, mapping vertical integration of systems to horizontal platform layers.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Need1 hit
08
Faraday Future | Results Presentation Deck | 36 slidesFaraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Need1 hit
09
The visual uses a network node graphic to represent the AI concept.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
10
The slide uses a visual metaphor of a single car morphing into three different vehicle archetypes to demonstrate the technology's adaptability.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
11
Slide highlights class-leading battery energy and range.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
12
Faraday Future | Results Presentation Deck | 36 slidesFaraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
13
The slide uses a cross-section diagram of a vehicle chassis to demonstrate structural safety.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The slide uses a grid of four images to highlight core technological advantages of the Faraday Future vehicle.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The slide uses a three-column layout to categorize the technology stack: Sensors, Compute, and Software Features.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
16
The slide features a high-quality interior render of a vehicle with a large infotainment screen displaying a media interface.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The slide outlines a community-based co-creation model for Faraday Future.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Action1 hit
18
The slide uses a dark aesthetic with a silhouette of the FF 91 2.0 Futurist vehicle.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · Action1 hit
19
Includes photos of the vehicle and the team celebrating the milestone.Faraday Future | Results Presentation Deck | 36 slides · Faraday Future
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit